Cargando…

Vapocoolant Spray vs Lidocaine/Prilocaine Cream for Reducing the Pain of Venipuncture in Hemodialysis Patients: A Randomized, Placebo-Controlled, Crossover Study

Objective: Patients undergoing hemodialysis are repeatedly exposed to stress and pain from approximately 300 punctures per year to their arteriovenous fistula. This study was designed to measure pain associated with venepuncture during AVF cannulation and to compare the effectiveness of ethyl chlori...

Descripción completa

Detalles Bibliográficos
Autores principales: Çelik, Gülperi, Özbek, Orhan, Yılmaz, Mümtaz, Duman, Ipek, Özbek, Seda, Apiliogullari, Seza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198258/
https://www.ncbi.nlm.nih.gov/pubmed/22022215
_version_ 1782214401110048768
author Çelik, Gülperi
Özbek, Orhan
Yılmaz, Mümtaz
Duman, Ipek
Özbek, Seda
Apiliogullari, Seza
author_facet Çelik, Gülperi
Özbek, Orhan
Yılmaz, Mümtaz
Duman, Ipek
Özbek, Seda
Apiliogullari, Seza
author_sort Çelik, Gülperi
collection PubMed
description Objective: Patients undergoing hemodialysis are repeatedly exposed to stress and pain from approximately 300 punctures per year to their arteriovenous fistula. This study was designed to measure pain associated with venepuncture during AVF cannulation and to compare the effectiveness of ethyl chloride vapocoolant spray, topical eutectic mixture of local anesthetics (EMLA) cream and placebo in controlling pain caused by venepuncture of arteriovenous fistula patients undergoing chronic hemodialysis. Methods: This randomized, placebo-controlled, crossover study, included 41 patients undergoing conventional hemodialysis three times a week. First intervention was conducted as baseline pain assessment (control). In the three consecutive dialysis sessions, every patient randomly received 1) ethyl chloride vapocoolant spray, 2) EMLA, or 3) placebo cream before venepuncture. Pain perception was recorded by patients immediately after cannulation on a 0-100 mm visual analogue scale (VAS). p<0.05 was considered as significant. Results: VAS scores presented a marked inter-individual variation during venepuncture. EMLA application resulted in significantly lower total pain scores compared to control and all other interventions (p<0.05). No patient experienced severe pain with EMLA or vapocoolant. The patients reported less moderate and severe pain with EMLA, and vapocoolant spray compared to control and placebo interventions. Moderate and severe pain scores were similar between EMLA and vapocoolant spray (p>0.05). Conclusion: Venipuncture for AVF cannulation causes mild to moderate pain in hemodialysis patients. Although local application of EMLA is more effective than in preventing venepuncture pain, ethyl chloride vapocoolant is as effective as EMLA for preventing mild to moderate puncture pain in patients undergoing hemodialysis.
format Online
Article
Text
id pubmed-3198258
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-31982582011-10-21 Vapocoolant Spray vs Lidocaine/Prilocaine Cream for Reducing the Pain of Venipuncture in Hemodialysis Patients: A Randomized, Placebo-Controlled, Crossover Study Çelik, Gülperi Özbek, Orhan Yılmaz, Mümtaz Duman, Ipek Özbek, Seda Apiliogullari, Seza Int J Med Sci Research Paper Objective: Patients undergoing hemodialysis are repeatedly exposed to stress and pain from approximately 300 punctures per year to their arteriovenous fistula. This study was designed to measure pain associated with venepuncture during AVF cannulation and to compare the effectiveness of ethyl chloride vapocoolant spray, topical eutectic mixture of local anesthetics (EMLA) cream and placebo in controlling pain caused by venepuncture of arteriovenous fistula patients undergoing chronic hemodialysis. Methods: This randomized, placebo-controlled, crossover study, included 41 patients undergoing conventional hemodialysis three times a week. First intervention was conducted as baseline pain assessment (control). In the three consecutive dialysis sessions, every patient randomly received 1) ethyl chloride vapocoolant spray, 2) EMLA, or 3) placebo cream before venepuncture. Pain perception was recorded by patients immediately after cannulation on a 0-100 mm visual analogue scale (VAS). p<0.05 was considered as significant. Results: VAS scores presented a marked inter-individual variation during venepuncture. EMLA application resulted in significantly lower total pain scores compared to control and all other interventions (p<0.05). No patient experienced severe pain with EMLA or vapocoolant. The patients reported less moderate and severe pain with EMLA, and vapocoolant spray compared to control and placebo interventions. Moderate and severe pain scores were similar between EMLA and vapocoolant spray (p>0.05). Conclusion: Venipuncture for AVF cannulation causes mild to moderate pain in hemodialysis patients. Although local application of EMLA is more effective than in preventing venepuncture pain, ethyl chloride vapocoolant is as effective as EMLA for preventing mild to moderate puncture pain in patients undergoing hemodialysis. Ivyspring International Publisher 2011-10-12 /pmc/articles/PMC3198258/ /pubmed/22022215 Text en © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.
spellingShingle Research Paper
Çelik, Gülperi
Özbek, Orhan
Yılmaz, Mümtaz
Duman, Ipek
Özbek, Seda
Apiliogullari, Seza
Vapocoolant Spray vs Lidocaine/Prilocaine Cream for Reducing the Pain of Venipuncture in Hemodialysis Patients: A Randomized, Placebo-Controlled, Crossover Study
title Vapocoolant Spray vs Lidocaine/Prilocaine Cream for Reducing the Pain of Venipuncture in Hemodialysis Patients: A Randomized, Placebo-Controlled, Crossover Study
title_full Vapocoolant Spray vs Lidocaine/Prilocaine Cream for Reducing the Pain of Venipuncture in Hemodialysis Patients: A Randomized, Placebo-Controlled, Crossover Study
title_fullStr Vapocoolant Spray vs Lidocaine/Prilocaine Cream for Reducing the Pain of Venipuncture in Hemodialysis Patients: A Randomized, Placebo-Controlled, Crossover Study
title_full_unstemmed Vapocoolant Spray vs Lidocaine/Prilocaine Cream for Reducing the Pain of Venipuncture in Hemodialysis Patients: A Randomized, Placebo-Controlled, Crossover Study
title_short Vapocoolant Spray vs Lidocaine/Prilocaine Cream for Reducing the Pain of Venipuncture in Hemodialysis Patients: A Randomized, Placebo-Controlled, Crossover Study
title_sort vapocoolant spray vs lidocaine/prilocaine cream for reducing the pain of venipuncture in hemodialysis patients: a randomized, placebo-controlled, crossover study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198258/
https://www.ncbi.nlm.nih.gov/pubmed/22022215
work_keys_str_mv AT celikgulperi vapocoolantsprayvslidocaineprilocainecreamforreducingthepainofvenipunctureinhemodialysispatientsarandomizedplacebocontrolledcrossoverstudy
AT ozbekorhan vapocoolantsprayvslidocaineprilocainecreamforreducingthepainofvenipunctureinhemodialysispatientsarandomizedplacebocontrolledcrossoverstudy
AT yılmazmumtaz vapocoolantsprayvslidocaineprilocainecreamforreducingthepainofvenipunctureinhemodialysispatientsarandomizedplacebocontrolledcrossoverstudy
AT dumanipek vapocoolantsprayvslidocaineprilocainecreamforreducingthepainofvenipunctureinhemodialysispatientsarandomizedplacebocontrolledcrossoverstudy
AT ozbekseda vapocoolantsprayvslidocaineprilocainecreamforreducingthepainofvenipunctureinhemodialysispatientsarandomizedplacebocontrolledcrossoverstudy
AT apiliogullariseza vapocoolantsprayvslidocaineprilocainecreamforreducingthepainofvenipunctureinhemodialysispatientsarandomizedplacebocontrolledcrossoverstudy